Advertisement

Topics

Safety and Efficacy of Azelaic Acid Foam 15% in Papulopustular Rosacea

2014-07-23 21:11:33 | BioPortfolio

Summary

This study will investigate the safety and efficacy of a new formulation of an existing medication for the treatment papulopustular rosacea. The study will test the active ingredient plus foam against foam alone.

Study Design

Allocation: Randomized, Control: Placebo Control, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment

Conditions

Papulopustular Rosacea

Intervention

Azelaic acid foam 15%, Foam vehicle

Location

Boni Elewski
Birmingham
Alabama
United States
35294-5188

Status

Active, not recruiting

Source

Intendis GmbH

Results (where available)

View Results

Links

Published on BioPortfolio: 2014-07-23T21:11:33-0400

Clinical Trials [1426 Associated Clinical Trials listed on BioPortfolio]

Azelaic Acid Foam 15% in the Treatment of Papulopustular Rosacea

This research study is being performed to evaluate the photographic evidence of the efficacy and tolerability of Azelaic Acid Foam 15% in the treatment of papulopustular rosacea.

A Study to Evaluate Safety and Equivalence of Generic Azelaic Acid Foam and Finacea® Foam in Patients With Rosacea

The objectives of this study were to compare the safety and efficacy profiles of a generic Azelaic Acid Foam, 15% to the reference listed Finacea® (azelaic acid) Foam, 15% and to demonstr...

Exploratory Study of Azelaic Acid 15% Foam Compared to Vehicle in Patients With Papulopustular Rosacea

This exploratory study is being performed to determine whether a new form formulation of azelaic acid 15% is effective in the treatment of papulopustular rosecea.

To Evaluate the Therapeutic Equivalence and Safety in Treatment of Moderate Facial Rosacea

To demonstrate the superiority of the efficacy of the test and reference products over that of the placebo control in the treatment of moderate facial rosacea.

A Study to Evaluate the Safety and Efficacy of FMX103 1.5% Topical Minocycline Foam Compared to Vehicle in the Treatment of Facial Papulopustular Rosacea

The Primary Objectives of FX2016-11 are to determine the efficacy of FMX103 1.5% minocycline foam applied topically once daily for 12 weeks in the treatment of rosacea; and to evaluate the...

PubMed Articles [7574 Associated PubMed Articles listed on BioPortfolio]

The Efficacy and Safety of Azelaic Acid 15% Foam in the Treatment of Facial Acne Vulgaris.

Azelaic acid demonstrates anti-inflammatory, anti-oxidative, anti-comedogenic, and anti-microbial effects. Azelaic acid 20% cream is currently approved for the treatment of acne vulgaris, and azelaic ...

Bio-based thermosetting epoxy foam: Tannic acid valorization toward dye-decontaminating and thermo-protecting applications.

Bio-resourced thermosetting epoxy foam was synthesized from tannic acid toward two different applications e.g., dye-decontaminating and thermo-insulating. Epoxidized tannic acid (ETA) foam was produce...

Robust carbon nanotube foam for efficient electromagnetic interference shielding and microwave absorption.

Lightweight and robust carbon nanotube (CNT)/chitosan (CS) foams were assembled by a facile unidirectional freeze-drying method in this work. The CNT/CS foam exhibited an excellent electromagnetic int...

Rapid degradation of malachite green by CoFeO-SiC foam under microwave radiation.

This study demonstrated rapid degradation of malachite green (MG) by a microwave (MW)-induced enhanced catalytic process with CoFeO-SiC foam. The catalyst was synthesized from CoFeO particles and SiC ...

Transforming fish scale waste into an efficient filler for starch foam.

In this work modified fish scale waste (FS) was used as a filler in order to improve the properties of starch foam prepared by a baking process. The FS was modified under two calcination conditions: a...

Medical and Biotech [MESH] Definitions

A cutaneous disorder primarily of convexities of the central part of the FACE, such as FOREHEAD; CHEEK; NOSE; and CHIN. It is characterized by FLUSHING; ERYTHEMA; EDEMA; RHINOPHYMA; papules; and ocular symptoms. It may occur at any age but typically after age 30. There are various subtypes of rosacea: erythematotelangiectatic, papulopustular, phymatous, and ocular (National Rosacea Society's Expert Committee on the Classification and Staging of Rosacea, J Am Acad Dermatol 2002; 46:584-7).

A dry artificial sterile sponge of fibrin prepared by clotting with thrombin a foam or solution of fibrinogen. It is used in conjunction with thrombin as a hemostatic in surgery at sites where bleeding cannot be controlled by more common methods. (From Martindale, The Extra Pharmacopoeia, 30th ed, p648)

Agents used to prevent the formation of foam or to treat flatulence or bloat.

Lipid-laden macrophages originating from monocytes or from smooth muscle cells.

A family of scavenger receptors that mediate the influx of LIPIDS into MACROPHAGES and are involved in FOAM CELL formation.

More From BioPortfolio on "Safety and Efficacy of Azelaic Acid Foam 15% in Papulopustular Rosacea"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Mirvaso (brimonidine)
MIRVASO® (BRIMONIDINE) TOPICAL GEL, 0.33%* IS THE FIRST & ONLY FDA-APPROVED TREATMENT DEVELOPED AND INDICATED FOR PERSISTENT FACIAL REDNESS OF ROSACEA Mirvaso® (brimonidine) topical gel, 0.33% is an alpha adrenergic agonist indicated for th...


Searches Linking to this Trial